Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond.
about
L-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infantsPulmonary Hypertension in Children.Pulmonary hypertension's variegated landscape: a snapshot.Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration.Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growthProgress in the diagnosis and management of pulmonary hypertension in children.Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxiaExogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.Outcomes for extremely premature infantsImpaired pulmonary vascular development in bronchopulmonary dysplasia.Rescue Treatment with L-Citrulline Inhibits Hypoxia-Induced Pulmonary Hypertension in Newborn Pigs.Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia.Update on PPHN: mechanisms and treatment.Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia.Bronchopulmonary dysplasia: clinical perspective.Advances in bronchopulmonary dysplasia.Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia.Recent advances in the mechanisms of lung alveolarization and the pathogenesis of bronchopulmonary dysplasia.Mid-childhood outcomes after pre-viable preterm premature rupture of membranes.Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?Bronchopulmonary dysplasia: new becomes old again!Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury.Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.Persistent pulmonary hypertension of the newborn.Arginase inhibition prevents bleomycin-induced pulmonary hypertension, vascular remodeling, and collagen deposition in neonatal rat lungs.Tetrahydrobiopterin oral therapy recouples eNOS and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs.Persistent Pulmonary Hypertension of the Newborn.Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertensionAnti-inflammatory actions of endogenous and exogenous interleukin-10 versus glucocorticoids on macrophage functions of the newly bornDiagnosis and treatment of pulmonary hypertension in infancy.Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasia.Bronchopulmonary dysplasia-associated pulmonary hypertension: clues from placental pathology.The significance of IL-1β +3953C>T, IL-6 -174G>C and -596G>A, TNF-α -308G>A gene polymorphisms and 86 bp variable number tandem repeat polymorphism of IL-1RN in bronchopulmonary dysplasia in infants born before 32 weeks of gestation.An Echocardiographic Screening Program Helps to Identify Pulmonary Hypertension in Extremely Low Birthweight Infants with and without Bronchopulmonary Dysplasia: A Single-Center Experience.Structural and functional changes of the pulmonary vasculature after hypoxia exposure in the neonatal period - a new swine model of pulmonary vascular disease.Very low birthweight bronchopulmonary dysplasia survivors had similar cardiac outcomes to controls at six years to 14 years of age.Practices surrounding pulmonary hypertension and bronchopulmonary dysplasia amongst neonatologists caring for premature infants.Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.
P2860
Q26829856-AF611503-47FA-455B-8071-12175456DB8CQ30248871-EC75D15B-AE66-472E-B41A-7C6B761E7A80Q33738561-697E0872-6707-4521-90A1-DABED8C6A37DQ34003028-C51BA9D4-34D8-4BB6-B0EA-904595A67696Q34172135-7CDFF878-4CE4-4D48-AAED-351C8777611AQ34479289-18B0B854-D7AC-41E5-BF32-618B54CF0DACQ34987128-F1912549-77CB-478A-A0D5-B31355E255F9Q35086382-5D5C7522-D702-43B0-A5DB-13C656AF0740Q35113434-3E77C941-7DFF-4A2B-B917-9A1A0CAD276EQ35628109-3EC25718-D841-4911-A42C-8293B09458E5Q35747991-399C0D8A-3772-4F63-A7D9-1C2B8D015D1BQ36049218-067FAD0F-4119-4031-9DB8-86810BD89BE0Q36399859-5609AEC7-AA31-499B-8043-92CDCC975E17Q37540307-0F1C0685-DFB0-4814-AE17-E879381A78FEQ37617591-96E00A73-CFF9-429F-9FAF-2A457C5E8DCFQ38161431-55ABEF59-EDCD-4ED1-8767-B71ED3233890Q38191861-C7288680-B53E-4729-9DC7-21078AC7F8DAQ38199172-D723FA8D-3B1D-4882-AFE0-9C31CC0DA575Q38271628-9436B20D-2A27-4DD9-93F4-5EB3E2F20F63Q38585146-585E38B5-C58D-464B-B3CB-DA7EF7917B09Q38665143-DBF12778-C43F-42DF-89D1-FE2E10512427Q38821344-9DC8AE08-103A-49EB-88A0-47A359899F7CQ38967345-3EEDB191-A78A-4374-859B-A52669FB80BEQ39011644-BF9B10AD-BC4D-4EF3-BE5A-91B921FF3C90Q39024836-D7322B2C-57D4-4A4D-8C42-228DEF58E71AQ39940901-663A0A03-EF37-4012-A990-5BF47396F6B4Q41572196-017CE582-EFFE-42E7-AA14-AB081FFDF784Q41630719-6FD9D39E-33AA-40D6-AEA2-3B1F04CD500DQ42123924-CCAE5D27-8344-478F-96B4-83AA9902C7F1Q42174480-182D5775-3391-4DE3-AB0E-DD3C5D90E9BDQ42217159-9816B567-F7BC-4267-9E29-8DAAF122D48BQ42508912-69F2E668-4C87-4174-89A9-379A186E5C63Q45743135-938B5616-3B54-4CF7-A042-208E8E892A71Q46302803-3C7DD9E6-74A8-4077-8CEC-1B7E07C91908Q47117496-71B91DCC-1CAA-4AC6-97B7-362B19F79F66Q47219462-227D0654-BFAA-405C-91F7-86E5A02D7E70Q47583015-DC6727B5-717C-41D4-83D6-5B1EBC541E30Q47648427-CAC57B8C-EC24-4ACF-BE2C-CEE176DD8030Q48130185-35CB156B-35C8-403B-843F-31483E6DE077Q48490217-D834C1A2-D2E4-45B9-B8C8-D3CD53B3D284
P2860
Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pulmonary vascular disease in ...... onary hypertension and beyond.
@en
type
label
Pulmonary vascular disease in ...... onary hypertension and beyond.
@en
prefLabel
Pulmonary vascular disease in ...... onary hypertension and beyond.
@en
P1476
Pulmonary vascular disease in ...... onary hypertension and beyond.
@en
P2093
Peter M Mourani
Steven H Abman
P304
P356
10.1097/MOP.0B013E328360A3F6
P577
2013-06-01T00:00:00Z